USPTO serial 99656892
DENDURA
Reviewed by CopyMark Law Group
Status 688Notice of Allowance
- Filing date
- Status date
- Registration date
- —
- Examiner
- MICHELI, ANGELA M
- Law office
- INTENT TO USE SECTION
What this means
The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.
Deadline: March 15, 2027
Need help with DENDURA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $947*
Plus Government fees of $450
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Polymers and polymeric additives for use in the manufacture of pharmaceutical preparations, medical devices, plastics, cosmetics, personal care products, coatings, adhesives, and lubricants; Medical grade polyurethanes for use in the manufacture of medical tubing, films, sprays, and membranes; Unprocessed artificial resins as raw materials in the form of powders, liquids or pastes; Unprocessed polyurethane resins; Unprocessed polymer resins; Unprocessed artificial and synthetic resins; Unprocessed synthetic resins for use in the manufacture of medical devices; Unprocessed thermoplastic compounds, thermoplastic elastomer resins and thermoplastic concentrates for use in manufacturing in a wide variety of industries | ACTIVE | — |
| 010 | Medicinal catheters; Catheters; Vascular ports; Central venous catheters; Artificial vascular grafts; Vascular access ports for medical use; Medical and surgical catheters; Surgical drains; Medical apparatus for monitoring blood glucose levels; Devices for monitoring blood glucose for medical purposes; Implantable drug delivery ports; Intravenous catheters; Intravenous bags sold empty for intravenous therapy; Intravenous feeding tubes; Medical introducers; Trocars; Dialysis machines; Artificial cardiac valves; Artificial heart-lung machines; Biocompatible coated stents; Stents; Medical stents; Filter delivery system for the placement of medical blood filters; Implantable blood filters made of artificial materials; Filters for blood and blood components for medical purposes | ACTIVE | — |
| 017 | Polyurethanes in the form of sheets, films, pellets, granules, and tubes for use in the manufacture of medical devices, medical diagnostic devices, artificial vascular grafts, stents, pacemaker leads, artificial heart pump diaphragms, catheters, drug delivery devices, orthopedic and spinal implants, blood glucose monitors, and blood gas analyzers; Semi-worked synthetic plastic and synthetic resins as semi-finished products in form of pellets, rods, foils, foams, fibers, films and sheets; Extruded plastic in the form of pellets, rods, crumb or powder for use in manufacturing; Polyurethanes in the form of blocks, sheets, film, tubing, pellets and solutions for use in the manufacture of medical devices; Synthetic resins, semi-processed | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Polymerion BioSciences, LLC
- Other trademarks owned by Polymerion BioSciences, LLC
- Other trademarks in Class 001
- Other trademarks in Class 010
- Other trademarks in Class 017
- Similar marks named DENDURA
- Prosecution event NOAM explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 15, 2026 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 21, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 21, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 15, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 18, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 16, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 15, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 18, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 18, 2026 | NWAP | NEW APPLICATION ENTERED | — |